10-Hydroxyhexahydrocannabinol

10-Hydroxyhexahydrocannabinol
Identifiers
	IUPAC name (6aR,10R,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-hexhydro-6H-dibenzo[b,d]pyran-1,10-diol;
PubChem CID	44266786;
ChemSpider	23110560;
ChEMBL	ChEMBL10488;
Chemical and physical data
Formula	C21H32O3
Molar mass	332.484 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1(C)Oc2cc(CCCCC)cc(O)c2[C@@H]2[C@@H](O)C(C)CC[C@H]21;
	InChI InChI=1S/C21H32O3/c1-5-6-7-8-14-11-16(22)19-17(12-14)24-21(3,4)15-10-9-13(2)20(23)18(15)19/h11-13,15,18,20,22-23H,5-10H2,1-4H3/t13?,15-,18?,20+/m1/s1; Key:SUVXTOCRTNYFMQ-HQODNEQVSA-N;

10-Hydroxyhexahydrocannabinol (10-OH-HHC) is a semi-synthetic cannabinoid which has been sold as a designer drug, first identified in Germany in December 2024.^[1]^[2]

References

↑ "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.
↑ Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW (June 2020). "Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature". Toxics. 8 (2): 41. Bibcode:2020Toxic...8...41G. doi:10.3390/toxics8020041. PMC 7357058. PMID 32503116.

This cannabinoid related article is a stub. You can help Wikipedia by adding missing information.

[1] "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.

[Golombek_2020-2] Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW (June 2020). "Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature". Toxics. 8 (2): 41. Bibcode:2020Toxic...8...41G. doi:10.3390/toxics8020041. PMC 7357058. PMID 32503116.

[1]

[2]

This page was redesigned at the edge.

10-Hydroxyhexahydrocannabinol

See also

References